Do older men benefit from curative therapy of localized prostate cancer?
about
Optimal management of high-risk T1G3 bladder cancer: a decision analysisThe cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.Geriatric oncology: an overview of progresses and challenges.Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years.The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.Impact of age at diagnosis on prostate cancer treatment and survivalRadical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.Evaluation and Management of the Geriatric Urologic Oncology Patient.Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of ageHealth-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.A review and meta-analysis of prostate cancer utilities.Who's too old to screen? Prostate cancer in elderly menQuality of life and health status among prostate cancer survivors and noncancer population controls.Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis.Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented?Older age does not impact perioperative complications after robot-assisted radical prostatectomy.Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy.Radical radiotherapy for high-risk prostate cancer in older menSurvival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.Safety and feasibility of robot-assisted radical prostatectomy for clinically localized prostate cancer in elderly Japanese patientsSupport for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients.Open radical prostatectomy in the elderly: a case for concern?Long term results of HDR brachytherapy in men older than 75 with localized carcinoma of the prostate.Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy.Health care costs for state transition models in prostate cancer.[Management of prostate cancer in the elderly].Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.What is the best treatment strategy for incidentally detected small renal masses? A decision analysis.Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.Prostate-specific antigen screening for prostate cancer in older men in the United States of America.Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.Prostatic biopsies in selected men aged 75 years and older guide key clinical management decisions.Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
P2860
Q33300413-7947647E-4DA3-47E4-8ACA-062A798C508DQ33617669-F57C7094-FC5E-45BA-943C-953D80D471F2Q33979972-3FABE269-58B4-4B7D-A40B-D5B2DFD7E27DQ34294893-4D0AEB3F-8785-480C-8B7C-B0730D8CD7A0Q34380870-FAB6F323-8580-4F92-852F-CDE85CDDD209Q34659767-37C72EE4-6B70-4091-934C-64C0D16FE8DEQ34679220-BD43D30D-AA0F-492E-BCE5-E9A4AE9E34F7Q34747329-D6DF8496-3E72-4B47-A44B-4728992350E6Q35063815-52981426-B648-4B32-869D-AC25CD5A7504Q35673265-5C1C9FFE-E7D6-48A5-BE17-A46A76D6771AQ35789072-2137A672-0A49-450A-87D6-61FA65373720Q35806400-BA0CEFB4-8164-414A-9CC0-B0C9E700247EQ35834320-1953F466-776B-432A-BAE2-DE52E86A778BQ36234731-3DB443AC-E4AD-4EEA-9550-02015576911EQ36462112-FB705547-DDA3-4A4C-B7E4-560B15B28749Q36821787-31F905E1-75EA-49A2-B995-FDA6C519EB70Q37216126-CD23E7D9-EEC6-4F43-AA13-0CB5C060A347Q37626717-F9968820-838E-4513-B9C5-74179CC2350DQ37634841-5DD1CCE8-CE92-4F77-A235-714770F1D423Q38185481-9CD68511-7DF5-4C9F-A98B-FBF7DDCAE8D8Q38956794-A9D69BF8-C4CB-43DA-8D3F-AA7D065934B0Q39715470-B1B24763-BB74-4581-8A72-E939B8DE0038Q40149911-FB83B6FE-8943-4567-ACC3-C40A98760AC8Q41334584-7BD39F76-7468-46D5-B009-D974ADD4A761Q41848622-D39A33D4-1BFC-46DE-A75A-8170092F6588Q41967661-06B55614-7DB9-4FDD-AE52-E56AC8B414E1Q42315405-DC82B915-096F-4BB2-8BFA-DD4281443309Q42615432-EFD11291-AB0E-45C8-818B-8DB7DE41163DQ42794326-3894B07B-5EA7-4F74-8231-243A74D12E2CQ42955159-99714FD5-4858-4536-B046-BA1B5AC43EDFQ44031134-40A2069F-80DB-4707-8CD2-6C4572E770EBQ44613117-97416A73-41E8-4AF7-AE3F-9D680273A2BFQ44716909-EF1162B3-A66C-43A0-B690-5C46153D417AQ44781179-25FAD089-3956-4E02-8F37-4F04A2ED6523Q44977818-E5CA0086-313D-4963-9986-38D57DCF29D6Q45168057-BC106C28-D91A-4604-B714-BA024FFC97E5Q45747807-4B6946D4-5451-4AB9-A085-32183DA64F2BQ45926957-3A903BB1-FBAE-4A1F-BC5B-454ECCDAC57AQ46063759-49FBCD5A-36B0-456D-942F-EEBF5F0C7A8FQ47708045-29723F87-2759-498E-914B-E89F65533EED
P2860
Do older men benefit from curative therapy of localized prostate cancer?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Do older men benefit from curative therapy of localized prostate cancer?
@en
Do older men benefit from curative therapy of localized prostate cancer?
@nl
type
label
Do older men benefit from curative therapy of localized prostate cancer?
@en
Do older men benefit from curative therapy of localized prostate cancer?
@nl
prefLabel
Do older men benefit from curative therapy of localized prostate cancer?
@en
Do older men benefit from curative therapy of localized prostate cancer?
@nl
P2093
P356
P1476
Do older men benefit from curative therapy of localized prostate cancer?
@en
P2093
Gary Naglie
John Trachtenberg
Robert Nam
P304
P356
10.1200/JCO.2003.09.034
P407
P577
2003-09-01T00:00:00Z